Nebraska Center for Nanomedicine
Nebraska Center for Nanomedicine
批准号:
10163870
负责人:
David Oupicky
金额:
$114.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-01 至 2023-05-31
关键词:
AddressAreaBenchmarkingBiologicalBiological SciencesBiomedical ResearchCancer CenterCenters of Research ExcellenceClinicalClinical InvestigatorCollaborationsCommunitiesCore FacilityDevelopmentDevicesDiagnosisDiseaseDrug Delivery SystemsEarly DiagnosisEnvironmentEvolutionExtramural ActivitiesFacultyFosteringFundingFutureGene DeliveryGoalsGrowthHealth BenefitIndividualInfrastructureInterdisciplinary StudyInternationalLinkMedical centerMedicineMentorsMentorshipMethodologyMissionModalityNanotechnologyNebraskaPharmaceutical PreparationsPharmacologic SubstancePharmacy facilityPhaseProductivityRecombinant DNAResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesScientistSocietiesTalentsTechniquesTechnologyTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVisionVocational Guidancebasebioimagingbiomedical scientistcareercareer developmentclinical translationcollegecombateditorialhuman diseaseimprovedinnovationmaterials sciencemembermultidisciplinarynanomaterialsnanomedicinenanoscalenext generationnovel diagnosticsnovel therapeuticsprogramsrecruitresearch and developmentsenior facultyside effectsuccesssynergismtherapeutic genetherapeutic proteintumor
中文摘要
摘要
英文摘要
ABSTRACT
The multidisciplinary Nebraska Center for Nanomedicine (NCN), established in 2008 with the Center for
Biomedical Research Excellence (COBRE) funding, is building a nationally and internationally recognized
program of excellence in nanomedicine that combines broad expertise in material, pharmaceutical and
biological sciences driven by innovative research. NCN has completed its original objectives and enhanced
Nebraska's biomedical research capacity by creating a strategically linked infrastructure of strong research
programs and by mentoring a cadre of talented junior faculty to independent success. In the first 9 years of
funding, the NCN-funded junior faculty members obtained over $18 million in new research funds, eight NCN
trainees have been tenured and/or promoted, eight new junior and senior faculty with expertise relevant to
NCN were recruited to the College of Pharmacy. Our graduates have been appointed to editorial boards, serve
on review panels, and have countless invitations to present seminars. This NCN COBRE continuation proposal
details our plan to maintain a biomedical research center of national prominence and international recognition.
The specific aims that move the NCN toward these goals are: 1) continue to expand existing research
strengths through the support of collaborative interdisciplinary research and mentorship of junior faculty; 2)
strengthen research capabilities, innovation and funding support for investigators affiliated with the NCN; 3)
assure sustainability of scientific core facilities that are essential for the continued growth of the Center and
serve the research community at large. The realization of these aims will allow the NCN to emerge from Phase
III funding as self-sustaining center of research excellence in nanomedicine, with an increased capacity to
pursue programmatic support through individual and multi-investigator, program-wide research grants.
Through the development and clinical translation of effective nanomedicines for diagnosis and therapy for
human diseases, the NCN will ultimately provide significant benefits for the health of Nebraskans and society
at large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10356892
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10652269
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:10207371
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:9758400
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Pilot Projects
-
批准号:10163874
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9789273
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Nanomaterial Characterization Core
-
批准号:10163872
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10213017
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10434824
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9976515
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Administrative Core
-
批准号:10163871
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine
-
批准号:10441205
-
项目类别:
-
资助金额:$114.38万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nanoparticles based on histone deacetylase inhibitors for combination treatments
-
批准号:9043064
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Dual-function nanoparticles for oral treatment of inflammatory bowel disease
-
批准号:9047281
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8891423
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8701615
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:9314566
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8614186
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2013
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8302774
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2012
-
负责人:David Oupicky
-
依托单位:
Hollow porous silica nanoparticles for targeted drug delivery
-
批准号:7359747
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2007
-
负责人:David Oupicky
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: